Vol. 3 No. 3 (2024) | Bleeding, Thrombosis and Vascular Biology

Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years | BTVB Bioequivalence of von Willebrand factor-containing concentrates: implications for von Willebrand disease | BTVB Cardiovascular risk in hormone replacement therapy | BTVB Direct oral anticoagulants: does one dose fit all? Why, when and how testing | BTVB Cardiovascular risk profile evolution over 15 years: CV-PREVITAL vs Moli-sani Study | BTVB Launch of National Registry for Congenital Hematological Disorders in Palestine: Haemo-PAL | BTVB

Current Issue

Vol. 3 No. 3 (2024)

3 October 2024

View this Issue

Impact Factor 2025

Vol. 3 No. 3 (2024)

Published: 3 October 2024

Editorials

At the age of three

Giovanni de Gaetano, Chiara Cerletti

https://doi.org/10.4081/btvb.2024.166

959

PDF: 219
- PDF

Reviews

Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

Sarah Gallitto, Thomas C. Varkey, Jacob Lahti

https://doi.org/10.4081/btvb.2024.131

3337

PDF: 455
- PDF
The use of creatine and the development of deep vein thrombosis. A scoping review

Kartik Akkihal, Thomas Varkey, James Kelbert

https://doi.org/10.4081/btvb.2024.142

9038

PDF: 807

Supplementary: 210
- PDF
- Supplementary
Antithrombotic therapy in idiopathic infertility

Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso

https://doi.org/10.4081/btvb.2024.126

3522

PDF: 1259
- PDF

Mini-reviews

From rare to aware: confronting Lemierre syndrome

Silvia Cardi, Filippo Catalani, Luca Valerio, Stefano Barco

https://doi.org/10.4081/btvb.2024.147

2656

PDF: 595
- PDF

Special Articles

Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

https://doi.org/10.4081/btvb.2024.156

2161

PDF: 534

Appendix: 314
- PDF
- Appendix
Comments on "Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial"

Jozef Vermylen

https://doi.org/10.4081/btvb.2024.162

1097

PDF: 232
- PDF
Author's Reply. Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

https://doi.org/10.4081/btvb.2024.163

1087

PDF: 254
- PDF

Brief Reports

Thrombin generation assay in COVID-19 patients shows a hypocoagulable pattern

Giovanni L. Tiscia, Donatella Colaizzo, Antonio De Laurenzo, Filomena Cappucci, Lucia Fischetti, Elena Chinni, Mario Mastroianno, Giovanni Favuzzi, Massimo Carella, Elvira Grandone

https://doi.org/10.4081/btvb.2024.145

2495

PDF: 500

Supplementary: 263
- PDF
- Supplementary

Case Reports

Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes

Lisa Pieri, Silvia Linari, Francesca Salvianti, Monica Attanasio, Giancarlo Castaman

https://doi.org/10.4081/btvb.2024.150

1398

PDF: 449
- PDF

Commentaries

The 2024 Nobel prize in Medicine: impact on hemostasis and thrombosis research

Loredana Bury, Marco Malvestiti, Paolo Gresele

https://doi.org/10.4081/btvb.2024.159

1532

PDF: 385
- PDF
Synthetic platelets: can bioengineering realize in few years what evolution made in over 200 million years?

Paolo Gresele

https://doi.org/10.4081/btvb.2024.148

2315

PDF: 644
- PDF

Letters to the Editor

The intriguing association between cancer and congenital bleeding disorders

Ezio Zanon

https://doi.org/10.4081/btvb.2024.146

834

PDF: 187
- PDF

Abstract Book(s)

28^th SISET National Congress | Rome, Italy, 6-9 November 2024

Società Italiana per lo Studio dell'Emostasi e Trombosi – SISET

https://doi.org/10.4081/btvb.2024.160

2873

PDF: 608
- PDF

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.